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Abstract
Introduction: The ability to predetermine the fate of transplanted neural progenitor cells (NPCs) and specifically to
direct their maturation has the potential to enhance the efficiency of cell-transplantation therapy for
neurodegenerative disease. We previously demonstrated that transient exposure of subventricular zone (SVZ)-
derived adult NPCs to lithium chloride during in vitro proliferation alters differential fate in vitro and increases the
proportion of cells expressing neuronal markers while reducing glial progeny. To extend these findings, we
examined whether in vitro priming of adult SVZ-derived NPCs with lithium chloride before transplantation into the
quinolinic acid (QA) lesion rat model of Huntington disease altered in vivo neuronal differentiation and
sensorimotor function compared with nonprimed NPC transplants.
Methods: NPCs were isolated from the SVZ of the adult rat brain and cultured for 2 weeks. Four days before
transplantation into the QA-lesioned rat striatum, the cells were labeled with BrdU and primed with lithium
chloride. The rats underwent regular evaluation of forelimb use and sensorimotor neglect to establish functional
effects of NPC transplantation. Twelve weeks after transplantation, the brains were analyzed with
immunohistochemistry to compare the differential fate of primed and nonprimed NPCs.
Results: We observed that in vitro priming of adult NPCs with lithium chloride reduced gliogenesis and enhanced
the occurrence of DARPP-32-positive neurons when compared with nonprimed cells 12 weeks after transplantation
into the QA-lesioned striatum. Lithium chloride priming also augmented the formation of efferent projections from
newly formed neurons in the damaged host striatum to the globus pallidus. This was associated with acceleration
of sensorimotor function recovery in rats receiving transplants of lithium chloride-primed adult NPCs compared
with nonprimed transplants.
Conclusions: These initial findings indicate that in vitro priming of adult NPCs with lithium chloride may augment
transplant efficiency and accelerate sensorimotor function outcome in vivo.
Introduction
Cell-transplantation therapy offers a viable treatment
strategy for a range of neurodegenerative disorders,
including Huntington disease (HD) [1-3]. Cell transplan-
tation for HD has developed over the last decade to clini-
cal trials of human fetal striatal tissue in the United
States, France, and the United Kingdom [4]. However,
the supply of human fetal tissue is limited and difficult to
develop as a routine systematized source. This has led to
neural progenitor cell (NPC) populations being investi-
gated as an alternative source of cells for transplantation
therapy for HD. Although initial studies have investigated
NPCs obtained from a range of sources, they have all
demonstrated limited mature neuronal differentiation
with varying levels of sensorimotor function improve-
ment [5-9]. Specifically, we previously demonstrated that
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transplantation, generate new striatal neurons, and
improve sensorimotor function in the quinolinic acid
(QA)-lesion model of HD [9]. However, in agreement
with other studies [10-14], we observed the majority of
transplanted adult NPCs generated glial fibrillary acidic
protein (GFAP)-positive astrocytes. Regional environ-
mental cues present in the adult brain play a key role in
determining the lineage potential of NPCs [10,12,13,15].
We propose that microenvironmental changes induced
by a CNS lesion in non-neurogenic brain regions are not
sufficient to induce extensive neuronal differentiation
from transplanted NPCs. As limited neuronal differentia-
tion of transplanted NPCs may result in incomplete func-
tional recovery, it is necessary to develop an effective
strategy by which the neuronal fate of NPCs can be pre-
determined before transplantation.
We recently established an effective strategy that
allows us to “prime” adult NPCs toward a neuronal cell
fate in a controlled in vitro environment before trans-
plantation. We demonstrated that priming SVZ-derived
adult NPCs with lithium chloride increased the propor-
tion of cells expressing neuronal markers while reducing
glial progeny [16]. The use of lithium chloride as a
priming agent to promote neuronal differentiation is
supported by previous studies that demonstrate the abil-
ity for lithium chloride to increase neuronal differentia-
tion of both fetal and adult hippocampal NPC cultures
in vitro, as well as to augment adult hippocampal neuro-
genesis in vivo [17-19].
The current study extends our previous findings by
examining whether in vitro priming of adult SVZ-
derived NPCs with lithium chloride before transplanta-
tion into the QA lesion rat model of HD can enhance
in vivo neuronal differentiation and sensorimotor func-
tion recovery.
Materials and methods
Animals
Adult male Wistar rats (University of Auckland Vernon
Jansen Unit) 250 to 300 g (8 weeks old) at the time of
QA lesion were used in this study. All procedures
strictly complied with the University of Auckland Ani-
mal Ethics Guidelines, in accordance with the New
Zealand Animal Welfare Act 1999 and international
ethical guidelines. All efforts were made to minimize the
number of animals used and their suffering. The rats
were randomly allocated into the following treatment
groups: nonprimed NPC transplants (n = 12); lithium
chloride-primed NPC transplants (n =1 1 ) ;a n ds h a m
transplants (n = 8). The animals were group housed in a
temperature- and humidity-controlled room on a 12-
hour light/dark cycle. Food and water were available ad
libitum throughout the study, except for food-
deprivation requirements for motor-function analysis, as
noted later.
Isolation, expansion, and priming of adult neural
progenitor cells
Neural progenitor cells (NPCs) were isolated from the
SVZ of adult male Wistar rats, 250 to 300 g, and cul-
tured as previously described [9,11,16] with retinoic
acid-free B27 (Invitrogen, Carlsbad, CA, USA). To visua-
lize transplanted adult rat NPCs and their progeny in
the host rat brain, neurospheres were labeled with bro-
modeoxyuridine (BrdU; 5 μM; Applichem, Darmstadt,
Germany) from days 10 to 14 of culture [9,11,16]. We
previously confirmed that BrdU labeling of transplanted
NPCs does not result in transfer of BrdU from dying
NPCs to host cells [11]. Priming was performed by add-
ing lithium chloride (3 mM final concentration) to the
proliferation medium from days 10 to 14 of culture [16].
We previously confirmed that treatment with lithium
chloride has no effect on NPC proliferation or viability
when compared with nonprimed NPC cultures [16].
The NPCs were harvested mechanically at day 14, rinsed
twice to remove residual BrdU, and resuspended for
transplantation in L15 (Invitrogen) with 6 mg/ml d-glu-
cose at ~37,500 cells/μl [9,11].
Surgical procedures
All surgeries were performed after an intraperitoneal
(i.p.) injection of sodium pentobarbital (60 mg/kg). All
rats received a unilateral intrastriatal infusion of quinoli-
nic acid (QA; 50 nmol, 400 nl; 100 nl/min with a 32G
Hamilton syringe controlled by a WPI UltraMicroPump
II) at the following stereotaxic coordinates: +0.7 mm
anterior-posterior (AP), ± 2.7 mm medial-lateral (ML),
relative to bregma, and -5.0 mm dorsal-ventral (DV)
from dura. Injections of NPCs (~150,000 viable cells per
animal) or L15 alone (sham) were performed 21 days
after QA lesioning into two adjacent sites in the
lesioned striatum (~37,500 viable cells/μl; 2 μl per injec-
tion site; 400 nl/min with a 26G Hamilton syringe) at
the following stereotaxic coordinates: +0.5 mm AP, ±
2.5 mm ML, at -5.0 and -4.0 mm DV [9,11]. To assess
whether transplanted adult NPCs formed anatomically
appropriate efferent projections, the neuronal tracer
hydroxystilbamidine, Fluorogold (0.2 μlo f2 %s o l u t i o n ;
FG; Invitrogen) was injected into the ispilateral globus
pallidus 11 weeks after transplant at the following
stereotaxic coordinates: -0.9 mm AP, ±3.5 mm ML, and
-6.0 mm DV.
Sensorimotor function analysis
Functional sensorimotor performance in the sponta-
neous exploratory forelimb-use test [20] and corridor
task [21-25] was assessed 1 week before QA lesioning, 3
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periodically for 12 weeks after transplantation by an
investigator blinded to treatment. Forelimb use was
assessed as a single asymmetry score representing the
overall ipsilateral forepaw use for rearing, wall place-
ment, and landing during exploratory rearing over a 5-
minute trial period in a clear Perspex cylinder (200 mm
internal diameter). The corridor task assessed ipsilateral
retrieval bias/contralateral sensorimotor neglect with
left/right food selection from adjacent containers evenly
spaced along a narrow corridor with retrievals analyzed
as ipsilateral or contralateral to the treated striatum.
The first 20 retrieval attempts (5 minutes maximum)
were recorded on each testing occasion. Rats were sub-
jected to fasting by food withdrawal for 12 hours before
corridor testing to elicit enhanced appetite for
motivation.
Immunohistochemical analysis
Rats were killed 12 weeks after transplantation with
sodium pentobarbital (120 mg/kg i.p.) followed by trans-
cardial perfusion with 0.9% saline and 4% paraformalde-
hyde. Brains were cryoprotected in 30% sucrose before
sectioning at 40 μm on a HM450 sliding microtome
(Microm International GmbH, Walldorf, Germany).
Eight sets of sections were collected from each brain
(distance of 320 μm between consecutive sections in
each set) and stored at -20°C.
Diaminobenzidine (DAB) peroxidase immunohisto-
chemistry was performed on free-floating coronal sec-
tions from each animal to identify transplanted BrdU-
labeled NPCs (mouse anti-Brd U ,1 : 2 5 0 ;B i l l e r i c a ,M A ,
USA). DNA was denatured in 2N hydrochloric acid at
37°C for 60 minutes and rehydrated in 0.1 M sodium
tetraborate (pH 8.5). The sections were blocked in Tris-
buffered saline containing 0.1% Triton X-100 with 3%
normal goat serum. After incubation with the primary
antibody, a biotinylated secondary antibody (1:500; goat
anti-mouse; Sigma-Aldrich, St. Louis, MO, USA) was
added before incubation in ExtrAvidin peroxidase
(1:500; Sigma-Aldrich). Antibodies were visualized by
using 0.4 mg/ml DAB, 25 mg/ml nickel sulfate, and
0.005% hydrogen peroxide in 0.2 M phosphate buffer.
Primary antibody dilutions for double-label immuno-
fluorescence were 1:250 for BrdU (mouse anti-BrdU Alexa
Fluor 594; Invitrogen), 1:250 for DARPP-32 (rabbit anti-
DARPP-32; Millipore), 1:500 for GFAP (rabbit anti-GFAP;
DAKO), 1:500 for NeuN (mouse anti-NeuN; Millipore),
and 1:50 for SOX2 (rabbit anti-SOX2; R & D Systems,
Minneapolis, MN, USA). In the detection of BrdU label-
ing, free-floating sections first underwent DNA denatura-
tion, as described earlier, before serial incubation with
appropriate primary antibodies. Secondary goat anti-rabbit
and goat anti-mouse Alexa Fluor 488 conjugated
antibodies (1:500; Invitrogen) were used. Fluorescently
labeled sections were imaged by using a confocal laser-
scanning microscope (Leica TCS SP2) equipped with UV,
argon, argon/krypton, and helium/neon lasers (Biomedical
Imaging Resource Unit, University of Auckland). All fig-
ures were compiled by using Adobe Photoshop (Adobe
Systems, Inc., San Jose, CA, USA).
Quantification
The number and distribution of BrdU-labeled adult
NPCs present in the QA-lesioned adult rat brain 12
weeks after transplantation were measured on DAB/
nickel sulfate-stained sections labeled for BrdU. To
determine the distribution of transplanted NPCs in the
lesioned hemisphere, an entire series from every animal
(320 μm distance between each section) was systemati-
cally analyzed at 20× magnification from both the ante-
rior (bregma +4.5 mm) and posterior maxima (bregma
-8.0 mm) inward until the first BrdU-labeled cell
nucleus and process was identified and recorded in
stereotaxic coordinates.
The number of BrdU-labeled NPCs in the QA-
lesioned hemisphere 12 weeks after transplantation was
quantified by using MicroBrightfield Neurolucida soft-
ware (Williston, VT, USA) on a Nikon e800 microscope
with MicroFire S99808 digital camera (Optronics, Musk-
ogee, OK, USA). Virtual slices were created at 20× mag-
nification of the ipsilateral hemisphere in one series
(bregma +2.20 mm to bregma -0.92 mm) from each ani-
mal that received an NPC transplant. With NIH Image
J, the virtual slices underwent semiautomated analysis
based on intensity thresholding and particle size to
determine the number of BrdU-positive particles.
Counts from one section per animal were verified with a
manual count by using Neurolucida software. Auto-
mated counts were then extrapolated by using Aber-
crombie’s correction [26].
Fluorescent double-label analysis was undertaken on a
Leica TCS SP2 confocal laser scanning microscope (Bio-
medical Imaging Resource Unit, University of Auckland).
Colocalization of BrdU and a cell marker or Fluorogold
was confirmed with z-series (interslice gap, 0.28 μm) and
orthogonal reconstruction through the cell of interest.
For quantification, a total of 500 transplanted cells per
animal within anterior, medial, and posterior sections of
the lesioned striatum for each phenotypic marker were
manually identified with confocal microscopy. For FG
analysis, all cells counted were from anterior and medial
sections of the striatum at least 1 mm rostral of the injec-
tion site to avoid confound due to passive diffusion. Each
channel was imaged sequentially with collection from
selective emission spectra to reduce cross-excitation or
bleed-through of fluorophores. Analysis was undertaken
blind to the treatment of each animal.
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Statistical analysis and graph composition was undertaken
by using GraphPad Prism version 4.02 for Windows
(GraphPad Software, San Diego, CA, USA). In text, values
and bar graphs are presented as mean ± standard error of
the mean (SEM); some graphs (Figure 1m and 1n) are pre-
sented as Tukey box-and-whisker plots. Two-tailed
unpaired Student t tests were used for direct comparisons
between primed and nonprimed NPCs. One-way or two-
way ANOVAs were used for multiple group comparisons
Figure 1 BrdU-labeled cells were found throughout the rostrocaudal axis of the QA-lesioned striatum 12 weeks after transplantation
of nonprimed (a through f) and lithium chloride-primed (g through l) transplants. No difference was found in the number (m) or
distribution (n) of BrdU-labeled cells between lithium chloride-primed and nonprimed transplants (Tukey box plot with min/max inner fences).
Boxed regions in (a through c) and (g through i) indicate the regions imaged in (d through f) and (j through l), respectively. Scale bar: (a
through c) and (g through i), 100 μm; (d through f) and (j through l), 25 μm. **P < 0.01.
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tistical significance was established at P <0 . 0 5 .
Results
Survival and migration of transplanted adult neural
progenitor cells
Neural progenitor cells (NPCs) were isolated from the
SVZ of the adult rat brain and cultured in proliferative
conditions for 14 days, including 4 days of priming with
lithium chloride. As we previously demonstrated [16],
lithium chloride priming had no effect on NPC prolif-
eration or viability when compared with nonprimed
NPC cultures. To enable detection of adult NPCs after
transplantation into the QA-lesioned rat striatum, cells
were labeled with BrdU 4 days before harvest. With
CldU and IdU co-labeling, we identified that the major-
ity of SVZ-derived adult NPCs exhibit a cell cycle of 18
to 26 hours. In agreement with previous studies [9,11],
this results in labeling of 83.86 ± 10.18% of NPCs with
BrdU, with no difference in labeling efficiency observed
between primed and nonprimed cultures (P = 0.79).
Twelve weeks after transplantation, BrdU-labeled
NPCs were distributed across the rostrocaudal axis of
the QA-lesioned striatum in all transplanted animals
(Figure 1a through 1l). Quantification of BrdU-labeled
cell number in the ipsilateral hemisphere between AP
+2.20 mm and -0.92 mm (relative to bregma) deter-
mined that lithium chloride priming did not augment
the survival of transplanted adult NPCs (32,680 ± 9,663
nonprimed (27%) versus 38,216 ± 13,113 primed (32%);
t20 = 0.33; P = 0.74; Figure 1m). Furthermore, lithium
chloride priming did not alter the maximal distribution
of NPCs across the striatum (AP +4.5 mm to -8.0 mm
relative to bregma) compared with nonprimed cells
(nonprimed = 1.5 ± 0.09 mm; primed = 1.67 ± 0.09
mm; t41 = 1.32; P = 0.19; Figure 1n).
Neuronal differentiation of transplanted adult neural
progenitor cells
To determine the resultant phenotype of the adult NPCs
12 weeks after transplantation into the QA-lesioned stria-
tum, we used BrdU labeling and double- or triple-label
immunofluorescence for cell type-specific markers.
Confocal microscopy revealed that 12 weeks after trans-
plantation, a small population of BrdU-labeled cells in
the QA-lesioned striatum co-expressed the immature
progenitor cell marker SOX2 (Figure 2a through 2d).
BrdU-labeled cells coexpressing SOX2 were observed in
both nonprimed and primed transplants. SOX2 is widely
expressed by adult rat SVZ-derived NPCs after 14 days of
in vitro proliferation [9,11,16]. In vitro priming
with lithium chloride significantly (Welch’s corrected
Figure 2 In vitro priming of SVZ-derived adult neural progenitor cells with lithium chloride reduces gliogenesis 12 weeks after
transplantation. Representative confocal micrographs in low power and in high power with orthogonal projections of BrdU-labeled lithium
chloride-primed adult neural progenitor cells co-expressing (a through d) the immature neural progenitor cell marker SOX-2, (f through i) the
astrocytic marker GFAP, and (k through n) the mature neuronal marker NeuN. Graphs comparing the proportion of transplanted BrdU-labeled
cells co-expressing (e) SOX2, (j) GFAP, or (o) NeuN labeling 12 weeks after transplantation. Scale bar, 40 μm (a, f, and k) and 20 μm (B-D, G-I, L-
N). *P < 0.05; ***P < 0.001.
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planted BrdU-labeled cells coexpressing SOX2 (Figure
2e). Rats that received lithium chloride-primed adult
NPC transplants exhibited a residual population of 1.82 ±
0.19% BrdU-labeled cells coexpressing SOX2, compared
with 2.56 ± 0.3% of BrdU-labeled cells that expressed
SOX2 in nonprimed adult NPCs 12 weeks after trans-
plantation. This suggests that in vitro priming of adult
NPCs with lithium chloride can direct NPCs away from
maintaining an immature phenotype in vivo.
Throughout the QA-lesioned striatum of rats that
received either primed or nonprimed transplants, we
observed a population of BrdU-labeled cells exhibiting a
mature astrocytic morphology and coexpressing the
astroglial marker GFAP (Figure 2f through 2i), with the
majority located close to the injection site. In agreement
with our previous data [16], in vitro priming of adult
NPCs with lithium chloride robustly decreased the pro-
portion (Welch’s corrected t19 = 5.16; P < 0.0001; Figure
2j) of BrdU-labeled cells coexpressing GFAP from 29.11
± 3.04% in nonprimed transplants to 11.78 ± 1.42% in
primed NPC transplants. An additional population of
BrdU-labeled cells within the QA-lesioned striatum
expressed the mature neuronal marker NeuN 12 weeks
after transplantation of either primed or nonprimed
adult NPCs (Figure 2k through 2n). However, in vitro
priming with lithium chloride did not significantly alter
(Welch’s corrected t19 =0 . 8 1 ;P =0 . 4 3 )t h ep r o p o r t i o n
of BrdU-labeled cells coexpressing NeuN when com-
pared with nonprimed cells (primed, 28.40 ± 4.0%; non-
primed, 24.73 ± 2.2%; Figure 2o). We also examined the
effect of in vitro priming with lithium chloride on the
phenotypic differentiation of transplanted adult NPCs.
In particular, we examined the effect of lithium chloride
on the generation of DARPP-32 positive cells, a marker
of striatal medium-sized spiny neurons representing the
main neuronal cell type lost in HD. Although the pro-
portion of BrdU-labeled cells coexpressing NeuN was
not altered by lithium chloride priming of adult NPCs,
we did observe a significant increase (t21 = 2.23; P =
0.035; Figure 3e) in the proportion of BrdU-labeled cells
coexpressing DARPP-32 in rats that received lithium-
primed (9.37 ± 0.98%) compared with nonprimed (6.99
± 0.55%) adult NPCs transplants (Figure 3a, b, d).
These results indicate that in vitro priming of adult
NPCs with lithium chloride can reduce the generation
of glial progeny after transplantation into the QA-
lesioned striatum. Although lithium chloride priming
alone did not increase the overall proportion of mature
neurons generated from transplanted adult NPCs, our
results suggest that lithium chloride priming is able to
enhance the phenotypic differentiation and/or matura-
tion of regionally specific DARPP-32 neurons in the
QA-lesioned striatum.
Formation of efferent projections
To assess whether transplanted adult NPCs formed ana-
tomically appropriate efferent projections, rats received
an injection of the retrograde tracer Fluorogold (FG)
into the globus pallidus 11 weeks after transplantation.
BrdU/DARPP-32/FG (Figure 3a through 3d) co-labeled
neuronal soma were identified in the lesioned striatum
of animals that received either nonprimed or lithium
chloride-primed adult NPC transplants. Quantitative
analysis determined that lithium chloride-primed trans-
plants produced significantly more BrdU/FG-colabeled
projections to the globus pallidus than did nonprimed
transplants by approximately 60% (nonprimed, 6.90 ±
1.14%; primed, 11.26 ± 1.52%; t18 =2 . 2 1 ;P = 0.040;
Figure 3f). FG is not taken up by fibers of passage
Figure 3 In vitro priming of SVZ-derived adult neural progenitor cells with lithium chloride enhances the formation of region-specific
mature neurons 12 weeks after transplantation. (a through d) Representative confocal micrographs with orthogonal projections of BrdU-
labeled lithium chloride-primed adult neural progenitor cells co-expressing DARPP-32, a marker of striatal medium-size spiny projection neurons
retrogradely co-labeled with Fluorogold (FG) from the globus pallidus. Graphs comparing the proportion of transplanted BrdU-labeled cells co-
expressing (e) DARPP-32, or (f) FG labeling 12 weeks after transplantation. Scale bar = 20 μm. *P < 0.05.
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DARPP-32/FG-colabeled soma in the QA-lesioned stria-
tum had processes that terminated in the globus palli-
dus. These findings further indicate that in vitro
priming of adult NPCs with lithium chloride enhances
neuronal maturation of transplanted adult NPCs in vivo
and augments the formation of anatomically appropriate
efferent projections from the damaged host striatum to
the globus pallidus.
Sensorimotor-function analysis
Rats were tested for spontaneous exploratory forelimb
use and ipsilateral retrieval bias to assess whether trans-
plantation of lithium chloride-primed adult NPCs could
augment sensorimotor-function improvement compared
with transplantation of nonprimed adult NPCs.
Spontaneous exploratory forelimb use
After QA lesioning, all treatment groups exhibited a
strong preference for use of the ipsilateral forelimb
Figure 4 Transplantation of lithium chloride-primed SVZ-derived adult neural progenitor cells accelerated the onset of sensorimotor-
function recovery after QA striatal lesioning compared with rats that received nonprimed transplants. Unilateral lesioning of the
striatum results in lateralized deficits to the rats’ sensorimotor behavior that was quantitatively assessed in (a) the spontaneous exploratory
forelimb-use test, and (b) sensorimotor-neglect corridor task to monitor the development of functional impairments after QA injection and
functional improvement after adult SVZ-derived neural progenitor-cell transplantation. Significance designated by repeated-measure two-way
analysis of variance (ANOVA) with Bonferroni post hoc analysis relative to sham transplant. *P < 0.05; **P < 0.01.
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way RM ANOVA, baseline and post-QA time points only;
Figure 4a). After transplantation, no change in ipsilateral
forelimb use in sham (media only) transplanted animals
was noted across the duration of the study (F(9, 45) = 0.68;
P =0 . 7 2 ;R Mo n e - w a yA N O V A ;F i g u r e4 a ) .H o w e v e r ,i n
animals that received a transplant of adult NPCs, two-way
repeated-measure ANOVA comparing sham with either
priming status at each time point confirmed a significant
effect of transplantation on forelimb asymmetry (F(2, 180) =
3.62; P = 0.008) and an interaction between transplanta-
tion and time (F(20, 180) =1 . 5 7 ;P = 0.01) with transplanted
animals, showing decreased ipsilateral forelimb use over
time (Figure 4a). In these animals, Bonferroni post hoc
analysis identified the onset of a sustained and significant
reduction in ipsilateral forelimb use in NPC-transplanted
compared with sham-transplanted animals from 7 weeks
after transplantation (P < 0.05; Figure 4a). In animals that
received lithium chloride-primed transplants, a sustained
and significant reduction in ipsilateral forelimb use com-
pared with sham animals was also identified at 7 weeks
after transplant (P < 0.01; Figure 4a). No significant differ-
ence in onset or extent of motor-function recovery was
identified through Bonferroni analysis of spontaneous
exploratory forelimb use between rats receiving trans-
plants of either nonprimed or lithium chloride-primed
NPC transplants (P > 0.05).
Corridor Task
QA-lesioned animals in each treatment group showed a
strong ipsilateral retrieval bias/contralateral sensorimo-
tor neglect in corridor-task performance (F(1, 24) =
207.1; P < 0.0001, two-way RM ANOVA, baseline and
post-QA time points only; Figure 4b). As with sponta-
neous exploratory forelimb-use analysis, no spontaneous
recovery was seen in sham-transplanted animals across
the 12-week period after transplant (F(9, 88) =0 . 6 1 ;P =
0.78; one-way RM ANOVA; Figure 4b). Rats that
received either nonprimed or lithium chloride-primed
adult NPC transplants showed a recovery from lesion-
induced ipsilateral bias with a return to baseline scores
by 12 weeks after transplantation (F(1, 21) =0 . 7 4 ;P =
0.54 baseline versus 12 weeks after transplant; Figure
4b). Both nonprimed and lithium chloride-primed adult
NPC transplants eventually resolved ipsilateral bias
(effect of transplant: F(2, 198) = 16.84; P < 0.0001; inter-
action between time and transplant: F(22, 198) = 2.62; P <
0.0001; two-way RM ANOVA; Figure 4b). Bonferroni
post hoc tests identified that animals with lithium chlor-
ide-primed NPC transplants showed a sustained and sig-
nificant reduction in ipsilateral bias from 4 weeks after
transplantation compared with sham-transplanted ani-
mals (P < 0.05). Furthermore, a significant preference
for contralateral retrievals was observed at 5 weeks after
transplant in rats receiving lithium chloride-primed
NPC transplants compared with both sham-transplanted
animals (P < 0.01) and animals receiving nonprimed
adult NPC transplants (P < 0.05). In contrast, animals
with nonprimed adult NPC transplants did not show a
significant reduction in ipsilateral bias compared with
sham-transplanted animals until 10 weeks after trans-
plantation (P < 0.05).
Combined, these results suggest that transplantation
of adult NPCs primed in vitro with lithium chloride can
accelerate the onset of sensorimotor-function recovery
compared with transplantation of nonprimed NPCs.
Discussion
Predetermining the fate of transplanted NPCs and direct-
ing their maturation will form a cornerstone for enhan-
cing the success of therapeutic transplantation. Our
results demonstrate that in vitro priming of adult NPCs
with lithium chloride before transplantation leads to a
reduction in gliogenesis and enhanced occurrence of
DARPP-32-positive neurons 12 weeks after transplanta-
tion into the QA-lesioned striatum. In addition, lithium
chloride priming increased the formation of anatomically
appropriate efferent projections and accelerated improve-
ment in sensorimotor-function performance when com-
pared with that of nonprimed adult NPC transplants.
Regional environmental cues present in the adult
brain play a strong role in determining the lineage
potential of adult NPCs. Previous studies have demon-
strated that transplantation of adult NPCs into homo-
trophic or heterotrophic neurogenic regions of the
normal brain results in site-specific neuronal differentia-
tion [14,29-31], whereas transplantation into non-neuro-
genic sites, such as the striatum, results in the majority
of transplanted cells differentiating into glia, with
approximately 0.1% to 9% of transplanted NPCs forming
neurons in either the normal brain, or in lesion models
of Parkinson disease or stroke [10,12,13,15]. We pre-
viously demonstrated that SVZ-derived adult NPCs dif-
ferentiate into GABAergic striatal neurons 8 weeks after
transplantation into the QA-lesioned striatum [9].
Nonetheless, the majority of transplanted adult NPCs
coexpressed the astrocytic marker GFAP. This indicates
that microenvironmental changes induced by a CNS
lesion in nonneurogenic brain regions are not sufficient
to induce extensive neuronal differentiation from trans-
planted adult NPCs.
This led us to develop a novel mechanism by which to
predirect the neuronal fate of adult NPCs before trans-
plantation to enhance therapeutic efficiency [16]. We
demonstrated that transient priming with lithium chlor-
ide during expansion of adult SVZ-derived NPCs in cul-
ture increased the proportion of cells expressing
neuronal markers, while concurrently reducing glial pro-
geny in vitro. Extending these observations, we now
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NPCs with lithium chloride before transplantation
reduces glial differentiation of transplanted NPCs in the
QA-lesioned striatum by nearly 60% compared with
nonprimed transplants. Reducing glial differentiation
from transplanted NPCs is important for optimizing
therapeutic efficacy, as this reduces the potential for
transplanted NPCs to contribute to gliosis. Preferential
differentiation of transplanted cells into astrocytes may
compound the neurologic consequences of glial scarring
and impede the development and functional integration
of transplant-derived neurons [32,33]; this is of particu-
lar concern for transplantation strategies targeted
toward HD due to preexisting glial scarring manifested
during the disease process [34-36].
In strong contrast with our previous in vitro observa-
tions [16], lithium chloride priming did not alter the
proportion of transplanted adult NPCs expressing the
mature neuronal marker, NeuN, when compared with
nonprimed transplants. However, we did observe an
increase in the proportion of transplanted adult NPCs
expressing the striatal phenotypic marker DARPP-32 in
rats that received lithium chloride-primed transplants
compared with nonprimed transplants. These results
suggest that although lithium chloride priming of adult
NPCs may not be sufficient to enhance the proportion
of newly generated neurons 12 weeks after transplanta-
tion, it may provide a mechanism by which to enhance
phenotypic differentiation or maturation or both of new
neurons in the lesioned striatum, possibly through
enhanced expression of the neurogenic factor BDNF
[37-41]. This is further supported by the observation
that lithium chloride priming augmented the formation
of anatomically appropriate efferent projections from
the damaged host striatum to the globus pallidus.
In accordance with the effect of lithium chloride prim-
ing on the formation of efferent projections from trans-
planted adult NPCs, rats that received lithium chloride-
primed transplants exhibited accelerated sensorimotor
function recovery compared with those with nonprimed
transplants. This was most prominent in the corridor
task, in which rats receiving lithium chloride-primed
NPCs exhibited an accelerated onset of sensorimotor-
function improvement compared with rats with non-
primed transplants. Most surprising, a significant prefer-
ence for contralateral retrievals was observed at 5 weeks
after transplant in rats receiving lithium chloride-primed
NPC transplants compared with both sham-transplanted
animals and animals receiving nonprimed adult NPC
transplants. Although the mechanism resulting in this
contralateral recovery bias is unclear, it may reflect the
effect of lithium chloride priming on efferent fiber
growth and anatomic integration of transplanted cells
with the host.
The molecular mechanisms by which lithium chloride
priming directs the differentiation, maturation, survival
(or a combination of these) of adult SVZ-derived NPCs
remains to be specifically clarified. Previous studies have
demonstrated that lithium chloride activates a number
of cell-survival factors including the PI3-kinase/Akt sig-
naling pathway, and neurotrophic/neuroprotective pro-
teins such as BDNF, heat-shock protein, and Bcl-2 [42],
as well as promoting neurogenesis through activation of
the Wnt/MAPK, ERK-, and CREB-dependent signaling
pathways [17,18,43,44].
Alternatively, lithium chloride has been shown to
increase the active form of the Notch receptor and
upregulate its target genes in SVZ-derived NPCs inde-
pendent of GSK-3b or inositol signaling [45]. Lithium
chloride is well known to act as a direct inhibitor of gly-
cogen synthase kinase-3 (GSK-3), a component of the
canonic Wnt signaling pathway. Wexler and colleagues
[17] demonstrated that treatment of adult hippocampal
NPCs with lithium chloride in vitro increased prolifera-
tion and enhanced neuronal differentiation through
inhibition of GSK-3a/b, suggesting that much of lithium
chlorides effect on neurogenesis may be attributable to
activation of the canonic Wnt pathway. Supporting this
hypothesis, Kim and colleagues [18] demonstrated that
treatment of adult rats with lithium chloride increased
the proportion of BrdU-labeled hippocampal NPCs cells
expressing p-CREB. In addition, Su and colleagues [46]
demonstrated that treatment of spinal cord-derived
NPCs with lithium chloride increased proliferation,
BDNF production and neuronal differentiation of NPCs
in vitro. Inhibition of GSK-3 by lithium chloride in rat
cortical neurons increases BDNF by activating BDNF
promoter IV [43,44]. This suggests that the CREB-
BDNF pathway is involved in the neurogenic effect
observed both in vitro and in vivo after priming of adult
NPCs with lithium chloride.
Based on these previous findings, we propose that
inhibition of GSK-3 in adult SVZ-derived NPCs before
transplantation may facilitate CREB activation and
increase the expression and production of BDNF,
thereby enhancing NPC differentiation or maturation or
both. This is in agreement with our previous findings in
which we demonstrated that ectopic expression of
BDNF in the striatum promoted neuronal differentiation
of transplanted adult SVZ-derived NPCs [15].
Conclusions
These initial results demonstrate the potential for
lithium chloride priming to augment neuronal phenoty-
pic differentiation, maturation, and functional integra-
tion of transplanted adult NPCs in the QA-lesion rat
model of HD. Priming NPCs toward a specific neuronal
fate in a controlled in vitro environment before
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Page 9 of 11transplantation has the potential to enhance the effi-
ciency of NPC transplantation therapy. Whereas the QA
lesion model was used in this initial study to provide a
rapid, reliable, and well-substantiated model of the
selective and extensive striatal cell loss observed in HD,
future studies using transgenic models of HD are neces-
sary to assess whether the diseased host brain affects the
long-term efficiency and survival of lithium chloride-
primed adult NPC transplants. Future analysis regarding
the molecular mechanisms by which lithium chloride
directs neuronal differentiation of adult SVZ-derived
NPCs may also allow the identification and development
of more specific modulators of neuronal fate.
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